Sidi Yang

450 total citations
21 papers, 267 citations indexed

About

Sidi Yang is a scholar working on Molecular Biology, Infectious Diseases and Immunology. According to data from OpenAlex, Sidi Yang has authored 21 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Infectious Diseases and 4 papers in Immunology. Recurrent topics in Sidi Yang's work include SARS-CoV-2 and COVID-19 Research (7 papers), Salmonella and Campylobacter epidemiology (4 papers) and COVID-19 Clinical Research Studies (4 papers). Sidi Yang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Salmonella and Campylobacter epidemiology (4 papers) and COVID-19 Clinical Research Studies (4 papers). Sidi Yang collaborates with scholars based in China and Canada. Sidi Yang's co-authors include Shuyan Wu, Rui Huang, Yuanyuan Li, Lixin Hua, Fanghai Han, Jiong Wu, Yuanyuan Li, Yulong He, Deyin Guo and Liu Cao and has published in prestigious journals such as The FASEB Journal, Redox Biology and Fish & Shellfish Immunology.

In The Last Decade

Sidi Yang

19 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sidi Yang China 11 134 64 58 45 45 21 267
Rebecca N. Nix United States 7 206 1.5× 47 0.7× 43 0.7× 52 1.2× 78 1.7× 9 379
Dario Siccardi United Kingdom 8 114 0.9× 44 0.7× 113 1.9× 56 1.2× 10 0.2× 9 376
Josias Brito Frazão Brazil 10 196 1.5× 57 0.9× 111 1.9× 31 0.7× 92 2.0× 14 453
Georg Schneditz Austria 6 181 1.4× 17 0.3× 35 0.6× 37 0.8× 19 0.4× 6 291
Lena Schütte Germany 9 212 1.6× 14 0.2× 33 0.6× 83 1.8× 33 0.7× 11 388
D M Quinn Australia 8 166 1.2× 19 0.3× 81 1.4× 39 0.9× 22 0.5× 13 370
Roberto Pierini United Kingdom 10 337 2.5× 20 0.3× 151 2.6× 22 0.5× 27 0.6× 11 466
Boram Choi South Korea 12 221 1.6× 30 0.5× 21 0.4× 16 0.4× 146 3.2× 35 501
Yeung‐Hyen Kim United States 11 164 1.2× 41 0.6× 120 2.1× 44 1.0× 16 0.4× 13 324
Pavel Filipčík New Zealand 5 278 2.1× 49 0.8× 49 0.8× 38 0.8× 27 0.6× 7 383

Countries citing papers authored by Sidi Yang

Since Specialization
Citations

This map shows the geographic impact of Sidi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidi Yang more than expected).

Fields of papers citing papers by Sidi Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sidi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidi Yang. The network helps show where Sidi Yang may publish in the future.

Co-authorship network of co-authors of Sidi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Sidi Yang. A scholar is included among the top collaborators of Sidi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sidi Yang. Sidi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Peisen, Guanguan Li, Shuo Li, et al.. (2025). Mini review: SHEN26, a novel oral antiviral drug for COVID-19 treatment. Bioorganic & Medicinal Chemistry Letters. 124. 130243–130243. 1 indexed citations
2.
Li, Kun, Konstantin I. Ivanov, Sidi Yang, et al.. (2025). Anti-SARS-CoV-2 prodrug ATV006 has broad-spectrum antiviral activity against human and animal coronaviruses. Acta Pharmaceutica Sinica B. 15(5). 2498–2510. 1 indexed citations
3.
Zhou, Xinrong, Hongchao Liu, Sidi Yang, et al.. (2025). Rapid Generation of Reverse Genetics Systems for Coronavirus Research and High‐Throughput Antiviral Screening Using Gibson DNA Assembly. Journal of Medical Virology. 97(1). e70171–e70171.
4.
Zhou, Jun, Peisen Zheng, Sidi Yang, et al.. (2025). Identification and Evaluation of Non-Nucleosidic MTase Inhibitors against SARS-CoV-2 nsp14 with Lower-Micromolar Anti-Coronavirus Activity. ACS Infectious Diseases. 11(8). 2145–2156.
5.
Huang, Kai, Yuan Zhu, Yu Cao, et al.. (2024). REV-ERBα negatively regulates NLRP6 transcription and reduces the severity of Salmonella infection in mice. Heliyon. 10(8). e28432–e28432. 2 indexed citations
6.
Zhou, Qifan, Sidi Yang, Chao Yang, et al.. (2024). Identification of adenosine analogues as nsp14 N7‑methyltransferase inhibitors for treating coronaviruses infection. Bioorganic Chemistry. 153. 107894–107894. 1 indexed citations
7.
Yang, Sidi, Kai Huang, Yu Cao, et al.. (2024). NLRP6 induces RIP1 kinase-dependent necroptosis via TAK1-mediated p38MAPK/MK2 phosphorylation in S. typhimurium infection. iScience. 27(4). 109339–109339. 2 indexed citations
8.
Zhou, Qifan, Sidi Yang, Yongzhi Chen, et al.. (2024). Development of pyrimidone derivatives as nonpeptidic and noncovalent 3-chymotrypsin-like protease (3CLpro) inhibitors with anti-coronavirus activities. Bioorganic Chemistry. 154. 107988–107988. 2 indexed citations
9.
Cao, Liu, Jun Zhou, Sidi Yang, et al.. (2023). Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2. Antiviral Research. 213. 105586–105586. 14 indexed citations
10.
Liu, Lihong, Jie Du, Sidi Yang, et al.. (2023). SARS-CoV-2 ORF3a sensitizes cells to ferroptosis via Keap1-NRF2 axis. Redox Biology. 63. 102752–102752. 30 indexed citations
11.
Yang, Sidi, Liu Cao, Yanxi Ji, et al.. (2022). Comparison of model‐specific histopathology in mouse models of COVID‐19. Journal of Medical Virology. 94(8). 3605–3612. 10 indexed citations
12.
Zeng, Weijie, Fan Xing, Yanxi Ji, et al.. (2022). Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. 12. 911313–911313. 4 indexed citations
13.
Yang, Sidi, Kai Huang, Yu Cao, et al.. (2022). Salmonella pSLT-encoded effector SpvB promotes RIPK3-dependent necroptosis in intestinal epithelial cells. Cell Death Discovery. 8(1). 44–44. 16 indexed citations
14.
Peng, Hong, Sidi Yang, Jie Du, et al.. (2022). A soluble DR5‐Fc chimeric protein attenuates inflammatory responses induced by coronavirus MHV‐A59 and SARS‐CoV‐2. Journal of Medical Virology. 94(11). 5574–5581. 5 indexed citations
15.
16.
Yang, Sidi, et al.. (2021). Salmonella Effector SpvB Inhibits NF-κB Activity via KEAP1-Mediated Downregulation of IKKβ. Frontiers in Cellular and Infection Microbiology. 11. 641412–641412. 19 indexed citations
17.
Yang, Sidi, Kai Huang, Yu Cao, et al.. (2021). A detrimental role of NLRP6 in host iron metabolism during Salmonella infection. Redox Biology. 49. 102217–102217. 12 indexed citations
18.
Yang, Sidi, et al.. (2019). Salmonella effector SpvB interferes with intracellular iron homeostasis via regulation of transcription factor NRF2. The FASEB Journal. 33(12). 13450–13464. 31 indexed citations
19.
Wu, Shuyan, et al.. (2017). spv locus aggravates Salmonella infection of zebrafish adult by inducing Th1/Th2 shift to Th2 polarization. Fish & Shellfish Immunology. 67. 684–691. 12 indexed citations
20.
Han, Fanghai, et al.. (2014). Stromal-epithelial metabolic coupling in gastric cancer: Stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors. European Journal of Surgical Oncology. 40(10). 1361–1368. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca N. Nix Breakdown of academic impact, for papers by Dario Siccardi Breakdown of academic impact, for papers by Josias Brito Frazão Breakdown of academic impact, for papers by Georg Schneditz Breakdown of academic impact, for papers by Lena Schütte Breakdown of academic impact, for papers by D M Quinn Breakdown of academic impact, for papers by Roberto Pierini Breakdown of academic impact, for papers by Boram Choi Breakdown of academic impact, for papers by Yeung‐Hyen Kim Breakdown of academic impact, for papers by Pavel Filipčík
Rankless by CCL
2026